OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Nephrology and Hypertension is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Dual organ transplantation: Pancreas and Liver in the kidney axis	38
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	38
Editorial introductions	26
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	26
Maximizing opportunities for kidney transplantation in older adults	25
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	24
Interferon gamma in the pathogenesis of hypertension − recent insights	22
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	21
The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated	19
The impact of conflicts on patients with chronic kidney disease	19
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	18
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	18
Editorial introduction	17
International equity in access to home dialysis	17
Prediction models for earlier stages of chronic kidney disease	16
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	16
Modern indications for referral for kidney and pancreas transplantation	16
Renal denervation for the treatment of hypertension and kidney disease	15
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	15
Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	13
Bringing the end-stage kidney disease life plan home	13
The race coefficient in glomerular filtration rate-estimating equations and its removal	13
Staying home when peritoneal dialysis ends: the integrated home dialysis approach	13
Plant-based diets for kidney disease prevention and treatment	13
Calcium-binding protein 39 in with-no-lysine kinase signaling and the modulation of renal tubular transport	12

Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	12
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	12
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	11
Sodium phosphate cotransporter 2a inhibitors: potential therapeutic uses	11
Editorial: One size does not fit all: moving toward individualized therapy	11
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	11
Built environment and chronic kidney disease: current state and future directions	11
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	11
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	11
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	10
Complement detection in kidney biopsies – utility and challenges	10
Bringing medical education “home”: the university health network and St. Michael's hospital home dialysis fellowship	10
Understanding renal phosphate handling: unfinished business	10
Combination therapy with kidney protective therapies: optimizing the benefits?	9
Cancer drugs and acute kidney injury: new therapies and new challenges	9
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	9
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	9
Editorial introductions	9
Editorial: Advancements in the management of kidney disease and electrolyte derangements	9
Lipocalin-2: a novel link between the injured kidney and the bone	9
A guide for program development of environmentally sustainable kidney care	9
A current update of the development of Chimeric Antigen Receptor T-cell therapy and kidney disease	9
Climate change and kidney stones	8
HIV-associated kidney disease: the changing spectrum and treatment priorities	8
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	8
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	8
Editorial introductions	8
Impact of intensive blood pressure control on kidney outcomes	8
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	8
When the earth shakes unexpectedly: impact on nephrology services and patients	8
Automation and innovation in home hemodialysis machines	8
Deep learning applications for kidney histology analysis	8
The current therapeutic approach for anaemia after kidney transplant	8
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	7
Recent advances in treatment options for kidney disease	7
Editorial introductions	7
Renal osteodystrophy: something old, something new, something needed	7
New and old approaches to nutritional management of acute and chronic glomerulonephritis	7
Prospects for gene therapy in polycystic kidney disease	7
Epithelial Na+ channel and the glycocalyx: a sweet and salty relationship for arterial shear stress sensing	7
Editorial introduction	7
Editorial introductions	7
Evolving thresholds for the diagnosis of acute T cell mediated rejection	7
New insights into renal calcium-sensing receptor activation	7
Hypernatremia in the intensive care unit	7
C3 glomerulopathy: advancements in diagnostics and therapeutics	6
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	6
Screening for chronic kidney disease: change of perspective and novel developments	6
Evolving indications and management patterns in heart – kidney transplantation	6
Renal denervation: recent developments in clinical and preclinical research	6

Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	6
Building kidney organoids from pluripotent stem cells	6
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	6
Prevention of postoperative acute kidney injury: insights from recent clinical trials	6
Sex differences in renal electrolyte transport	6
Vaccination in kidney disease: what did we learn from COVID-19 pandemic	6
Contemporary risk prediction models in chronic kidney disease: when less is more	6
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	6
Enhancing accuracy and adherence in blood pressure monitoring in living kidney donation: implementing technologies to overcome challenges	6
Chronic kidney disease and sex dimorphism	5
Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan	5
Novel approaches in antihypertensive pharmacotherapeutics	5
The changing trajectory of diabetic kidney disease	5
Cystatin C should be routinely available for estimating kidney function	5
Novel agents for treating IgA nephropathy	5
Frailty, multimorbidity and sarcopaenia in haemodialysis patients	5
The genetics of cystinuria – an update and critical reevaluation	5
New guidelines and therapeutic updates for the management of lupus nephritis	5
Staff-assisted peritoneal dialysis in the United States: from evidence to national adoption	5
An update on corticosteroid treatment for IgA nephropathy	5
Population health strategies for health equity in chronic kidney disease management	5
Targeting inflammation in hypertension	5
Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?	5
Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era	5
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?	5
New therapeutics for primary hyperoxaluria type 1	5
Peritoneal dialysis and heart failure	5
Fibroblast growth factor 23 as a risk factor for incident diabetes	5
Effects of aging on chronic kidney disease mineral and bone disorder	5